Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
35–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject is undergoing his/her first myocardial revascularization
You may not be if
Previous participation (randomisation and dosing) in this trial
Subject has a history of cerebrovascular event (including thrombotic or haemorrhagic stroke or transient ischaemic attack (TIA)) and/or extra-myocardial thromboembolic events, e.g., deep vein thrombosis (DVT) or pulmonary embolus (PE)
Subject required a pre-operative (within 30 days) transfusion of any blood and/or blood product
Subject has a current atrial fibrillation or history of atrial fibrillation
